Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatography
- 1 May 1995
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 667 (2) , 269-276
- https://doi.org/10.1016/0378-4347(95)00037-j
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1992
- Calibration and validation of linearity in chromatographic biopharmaceutical analysisJournal of Pharmaceutical and Biomedical Analysis, 1991
- A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activityInternational Journal of Cancer, 1989